Dollar remains weak ahead of Fed meeting; euro near highs
A federal court has denied class certification for direct purchaser plaintiffs in the multidistrict antitrust litigation against Keurig Dr Pepper Inc. (NASDAQ:KDP), according to a company statement released Friday in a filing with the Securities and Exchange Commission. The beverage giant, currently trading at $27.73 and sporting a market cap of $37.7 billion, appears undervalued according to InvestingPro analysis, despite facing this legal challenge.
The case, known as In re: Keurig Green Mountain Single-Serve Coffee Antitrust Litigation, is pending in the U.S. District Court for the Southern District of New York. The court determined that the direct purchaser plaintiffs did not meet the federal requirements necessary to pursue their claims on a classwide basis. Plaintiffs in this litigation had sought more than $3 billion in classwide monetary damages, a significant figure considering KDP’s impressive gross profit margins of 54.76%.
Following the court’s decision, the direct purchaser plaintiffs have filed a petition with the United States Court of Appeals for the Second Circuit, seeking to appeal the ruling. Keurig Dr Pepper stated it intends to continue defending the appeal and the remaining lawsuits in the multidistrict antitrust proceedings.
Additional details regarding the litigation are available in Note 15 of Keurig Dr Pepper’s Form 10-Q, filed on October 28, 2025. The information in this article is based on a press release statement included in the company’s SEC filing.
In other recent news, Keurig Dr Pepper reported its third-quarter 2025 earnings, meeting analysts’ expectations with an earnings per share of $0.54. The company exceeded revenue forecasts, reporting $4.31 billion compared to the anticipated $4.15 billion, marking a 3.86% revenue surprise. UBS reiterated a Buy rating on Keurig Dr Pepper, highlighting the company’s solid third-quarter results and an upward revision in its 2025 net sales growth outlook, while maintaining its earnings per share guidance. Additionally, TD Cowen raised its price target for Keurig Dr Pepper to $32 from $28, citing changes to the financing structure for the JDE Peet’s acquisition, which will reduce leverage by 1.0x. These recent developments have contributed to increased investor interest in the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.